March 05, 2014 16:00 ET

BIOLASE Declares Stock Dividend for 2014 First Quarter

IRVINE, CA--(Marketwired - Mar 5, 2014) - BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase®, and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today announced that its Board of Directors (the "Board") has declared a one-half percent stock dividend payable on March 28, 2014, to stockholders of record on March 14, 2014. In addition, the Board adopted a two percent annual stock dividend policy for 2014. 

While the foregoing stock dividend policy for 2014 is the current policy of the Board, the actual declaration of future stock dividends, and the establishment of record and payment dates, is subject to final determination by the Board after its review of the Company's financial performance, expected future operations and earnings, and any other factors as the Board may deem relevant. The Company's dividend policy may also be changed at any time, and from time to time, by the Board.

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's proprietary laser products incorporate approximately 300 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's® principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 25,000 lasers. Other laser products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at, Facebook at, Twitter at, Pinterest at, LinkedIn at, Google+ at, Instagram at and YouTube at

BIOLASE® and WaterLase® are registered trademarks or trademarks of BIOLASE, Inc.

Contact Information

  • For further information, please contact:
    Michael Porter
    Porter, LeVay & Rose, Inc.